ArticleInflammation2025

FDA-Approved Secukinumab Alleviates Glial Activation and Immune Cell Infiltration in MPTP-Induced Mouse Model of Parkinson's Disease.

Qi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.